Cost-Effectiveness Model Of Long-Acting Risperidone in Schizophrenia in the US
Year of publication: |
2005
|
---|---|
Authors: | Edwards, Natalie C. ; Rupnow, Marcia F.T. ; Pashos, Chris L. ; Botteman, Marc F. ; Diamond, Ronald J. |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 23.2005, 3, p. 299-314
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Cost-effectiveness | Haloperidol | Haloperidol-decanoate | Olanzapine | Risperidone | Schizophrenia |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Almond, Stephen, (2000)
-
Cost Effectiveness of Long-Acting Risperidone in Sweden
Hensen, Marja, (2010)
-
Olanzapine: A Pharmacoeconomic Review of its Use in Schizophrenia
Foster, Rachel H., (1999)
- More ...
-
Economic burden of head and neck cancer : a literature review
Lee, Jennifer M., (2004)
-
The Health Economics of Bladder Cancer: A Comprehensive Review of the Published Literature
Botteman, Marc F., (2003)
-
Zhang, Bin, (2011)
- More ...